# INQOVI

NDC: 64842-0727
Generic name: CEDAZURIDINE and DECITABINE
Labeler / Manufacturer: Taiho Pharmaceutical Co., Ltd.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20200707

FDA application: NDA212576

## Active ingredients

- CEDAZURIDINE: 100 mg/1
- DECITABINE: 35 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"64842-0727"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=64842-0727
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=91a0f80b-f865-4d06-a40d-4d148d99ee71